Secondary data was analyzed to arrive at the overall size of the global GLP-1 agonists market, which was validated through primary research
This class includes: Alendronate (Fosamax), Risedronate (Actonel), Ibandronate (Boniva), Zoledronic acid (Reclast)
announces the release of a market assessment report on the "Global GLP-1 Market Size, Share & Trends Analysis Report By Type of Molecule (Biologics and Small Molecules), Active Compound Used (Dulaglutide, Liraglutide, Orforglipron, Retatrutide, Semaglutide, Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type
Next, find your BMI on the chart below to see if youre within the indicated range for GLP-1 treatment: *The above chart is not meant for medical diagnosis purposes
Head-to-head efficacy comparison Retatrutide versus semaglutide is not even close in terms of raw weight loss numbers
Prescribing & titration and Direct consumers complete the main share leaders